Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On October 20, 2021, the Board of Directors of the Company appointed Pam
Randhawa as a director of the Company, effective November 1, 2021. There are no
arrangements or understandings between Ms. Randhawa and any other persons
pursuant to which Ms. Randhawa was elected as a director of the Company.
Ms. Randhawa will be entitled to the applicable annual retainer and restricted
stock awards pursuant to the Company's director compensation arrangements, under
terms consistent with those previously disclosed by the Company. Ms. Randhawa
will also be entitled to enter into an indemnification agreement with the
Company. Ms. Randhawa will hold office as a Class I director for a term expiring
in 2023 and will serve on the Nominating and Corporate Governance Committee of
the Board of Directors of the Company.
Ms. Randhawa has over 20 years of business leadership experience in the
healthcare and life sciences industries and brings to Hercules a wide range of
expertise ranging from policy, corporate strategy, product development, advanced
analytics and marketing for Fortune 500 companies, startups and government
entities. Since 2013, she has served as Chief Executive Officer and Founder at
Empiriko Corporation, a company that has developed a novel in vitro biomimetic
platform to accelerate small molecule drug development and is developing a
point-of-care diagnostic platform for personalized immunologic/genetic biomarker
and drug monitoring. Prior to founding Empiriko, Ms. Randhawa was President and
Co-Founder of AgroGreen Biofuels, an alternative biofuels technology company.
She has held several executive positions with major healthcare technology
companies, including McKesson Corporation (NYSE: MCK), Phase Forward (acquired
by Oracle), InfoMedics and Sermo. Ms. Randhawa currently serves on the Board of
Directors of the Massachusetts Life Sciences Center and as Vice Chair of the
Board of Directors of the Massachusetts Biotech Technology Council (MassBio).
Ms. Randhawa received her Bachelor of Science degree in Economics from the
University of Rajasthan and her Master in Public Management degree from Carnegie
Mellon University.
Item 8.01. Other Events
On October 20, 2021, the Company issued a press release announcing the
appointment of Ms. Randhawa as a member of the Company's Board of Directors. The
text of the press release is included as an exhibit to this Form 8-K.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release dated October 20, 2021
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses